Portman Square Capital’s Herbalife HLF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,186
Closed -$73.2K 271
2024
Q3
$73.2K Sell
10,186
-98,518
-91% -$907K ﹤0.01% 306
2024
Q2
$1.13M Buy
108,704
+5,218
+5% +$52.1K 0.04% 275
2024
Q1
$1.04M Buy
+103,486
New +$1.11M 0.03% 236
2023
Q4
Sell
-250,376
Closed -$3.46M 446
2023
Q3
$3.5M Buy
250,376
+87,243
+53% +$1.32M 0.09% 226
2023
Q2
$2.16M Sell
163,133
-36,512
-18% -$497K 0.06% 235
2023
Q1
$3.21M Sell
199,645
-32,486
-14% -$575K 0.15% 122
2022
Q4
$3.45M Buy
+232,131
New +$4.04M 0.25% 92

Other funds holding HLF

Portman Square Capital's HLF Position: Q4 2024 in Review

Portman Square Capital sold out of Herbalife (HLF) in Q4 2024, closing a stake of 10,186 shares — an estimated $73.2K sold.

Portman Square Capital first reported a position in HLF in Q4 2022 and held it in 7 quarters. The position peaked at $3.5M in Q3 2023. 199 funds tracked by Wall St. Rank hold HLF as of Q4 2024.

  • Portman Square Capital reported no remaining Herbalife position as of Q4 2024 after selling out during the quarter.
  • Portman Square Capital sold 10,186 Herbalife shares in Q4 2024, an estimated $73.2K.
  • Portman Square Capital first reported a position in Herbalife in Q4 2022 and held it in 7 quarters.
  • Portman Square Capital's Herbalife position peaked at $3.5M in Q3 2023.
  • 199 funds tracked by Wall St. Rank held Herbalife as of Q4 2024.

Based on Portman Square Capital's 13F filing for Q4 2024, filed 16 Jan 2025.